TLR4 and metabolic dysfunction-associated steatohepatitis: Patients with NASH often have an imbalanced gut microbiota, increased intestinal permeability, high LPS levels, and elevated expression of liver TLR4 (Abdel-Razik et al., 2018; Ghetti et al., 2019; Craven et al., 2020).